U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 329

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr12:111350880-111352114
MYL2Hypertrophic cardiomyopathy 10Uncertain significance
(Jul 5, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr12:111348881-111358333
MYL2Hypertrophic cardiomyopathy 10Uncertain significance
(Aug 10, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr12:111356888-111358333
MYL2Hypertrophic cardiomyopathy 10Uncertain significance
(Apr 8, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr12:111348881-111358333
MYL2Hypertrophic cardiomyopathy 10Uncertain significance
(Jun 22, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr12:111357006
GRCh38:
Chr12:110919202
LOC114827850, MYL2Hypertrophic cardiomyopathy 10Likely benign
(Sep 10, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr12:111358311
GRCh38:
Chr12:110920507
LOC114827850, MYL2Hypertrophic cardiomyopathy 10Likely benign
(Sep 1, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr12:111358317
GRCh38:
Chr12:110920513
LOC114827850, MYL2Hypertrophic cardiomyopathy 10Likely benign
(Aug 22, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr12:111351147
GRCh38:
Chr12:110913343
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Sep 10, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr12:111348951
GRCh38:
Chr12:110911147
MYL2P130L, P144L, P125LHypertrophic cardiomyopathy 10Uncertain significance
(Feb 20, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr12:111353528
GRCh38:
Chr12:110915724
MYL2A35T, A54THypertrophic cardiomyopathy 10Uncertain significance
(Feb 19, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr12:111351031
GRCh38:
Chr12:110913227
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Sep 10, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr12:111348979
GRCh38:
Chr12:110911175
MYL2V135F, V116F, V121FHypertrophic cardiomyopathy 10Uncertain significance
(Aug 30, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr12:111353506-111353522
GRCh38:
Chr12:110915702-110915718
MYL2Hypertrophic cardiomyopathy 10Uncertain significance
(Mar 23, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr12:111350891
GRCh38:
Chr12:110913087
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Apr 16, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr12:111348997
GRCh38:
Chr12:110911193
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Jun 8, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr12:111351978-111351979
GRCh38:
Chr12:110914174-110914175
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Jul 19, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr12:111357005
GRCh38:
Chr12:110919201
LOC114827850, MYL2Hypertrophic cardiomyopathy 10Benign
(Nov 30, 2021)
criteria provided, single submitter
18.
GRCh37:
Chr12:111348980
GRCh38:
Chr12:110911176
MYL2Hypertrophic cardiomyopathy 10Pathogenic
(Oct 13, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr12:111351054-111351055
GRCh38:
Chr12:110913250-110913251
MYL2D117*Hypertrophic cardiomyopathy 10Uncertain significance
(May 7, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr12:111353587
GRCh38:
Chr12:110915783
MYL2T34N, T15NHypertrophic cardiomyopathy 10Uncertain significance
(Apr 15, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr12:111350893
GRCh38:
Chr12:110913089
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Mar 31, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr12:111353611
GRCh38:
Chr12:110915807
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Mar 28, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr12:111348946
GRCh38:
Chr12:110911142
MYL2V132L, V127L, V146LHypertrophic cardiomyopathy 10Uncertain significance
(Feb 8, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr12:111353595
GRCh38:
Chr12:110915791
MYL2Hypertrophic cardiomyopathy 10Uncertain significance
(Jan 18, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr12:111348958
GRCh38:
Chr12:110911154
MYL2F123I, F128I, F142IHypertrophic cardiomyopathy 10Uncertain significance
(Sep 7, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr12:111352005
GRCh38:
Chr12:110914201
MYL2G87R, G73R, G68RHypertrophic cardiomyopathy 10Uncertain significance
(Dec 18, 2021)
criteria provided, single submitter
27.
GRCh37:
Chr12:111356951
GRCh38:
Chr12:110919147
LOC114827850, MYL2V17fsHypertrophic cardiomyopathy 10Uncertain significance
(Aug 5, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr12:111352001
GRCh38:
Chr12:110914197
MYL2E69A, E74A, E88AHypertrophic cardiomyopathy 10Uncertain significance
(Nov 29, 2021)
criteria provided, single submitter
29.
GRCh37:
Chr12:111353516
GRCh38:
Chr12:110915712
MYL2Hypertrophic cardiomyopathy 10Uncertain significance
(Jun 27, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr12:111348889
GRCh38:
Chr12:110911085
MYL2K151E, K165E, K146EHypertrophic cardiomyopathy 10Uncertain significance
(Jun 3, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr12:111348896
GRCh38:
Chr12:110911092
MYL2Hypertrophic cardiomyopathy 10Likely benign
(May 29, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr12:111351119
GRCh38:
Chr12:110913315
MYL2P76L, P81L, P95LHypertrophic cardiomyopathy 10Uncertain significance
(Nov 1, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr12:111350911
GRCh38:
Chr12:110913107
MYL2S131T, S112T, S117THypertrophic cardiomyopathy 10Uncertain significance
(May 22, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr12:111352043
GRCh38:
Chr12:110914239
MYL2P60R, P55R, P74RHypertrophic cardiomyopathy 10Uncertain significance
(May 2, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr12:111350913
GRCh38:
Chr12:110913109
MYL2F130Y, F116Y, F111YHypertrophic cardiomyopathy 10Uncertain significance
(Aug 10, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr12:111356983
GRCh38:
Chr12:110919179
LOC114827850, MYL2Hypertrophic cardiomyopathy 10, Cardiovascular phenotypeLikely benign
(Jan 19, 2023)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr12:111348963
GRCh38:
Chr12:110911159
MYL2A140V, A121V, A126VHypertrophic cardiomyopathy 10Uncertain significance
(Apr 16, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr12:111348973
GRCh38:
Chr12:110911169
MYL2Q118*, Q123*, Q137*Hypertrophic cardiomyopathy 10Uncertain significance
(Jul 19, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr12:111348906
GRCh38:
Chr12:110911102
MYL2I159T, I140T, I145THypertrophic cardiomyopathy 10, Cardiovascular phenotypeUncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr12:111348892
GRCh38:
Chr12:110911088
MYL2E145K, E150K, E164KCardiovascular phenotype, Hypertrophic cardiomyopathy 10Uncertain significance
(Sep 28, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr12:111352059
GRCh38:
Chr12:110914255
MYL2M69LHypertrophic cardiomyopathy 10Uncertain significance
(Feb 2, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr12:111351041
GRCh38:
Chr12:110913237
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Dec 9, 2020)
criteria provided, single submitter
43.
GRCh37:
Chr12:111350935
GRCh38:
Chr12:110913131
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Feb 18, 2021)
criteria provided, single submitter
44.
GRCh37:
Chr12:111352111
GRCh38:
Chr12:110914307
MYL2Hypertrophic cardiomyopathy 10Likely benign
(May 3, 2021)
criteria provided, single submitter
45.
GRCh37:
Chr12:111351983
GRCh38:
Chr12:110914179
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Oct 5, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr12:111353550
GRCh38:
Chr12:110915746
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Jun 28, 2021)
criteria provided, single submitter
47.
GRCh37:
Chr12:111353506
GRCh38:
Chr12:110915702
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Jan 1, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr12:111353589
GRCh38:
Chr12:110915785
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Jul 6, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr12:111350890
GRCh38:
Chr12:110913086
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Oct 24, 2021)
criteria provided, single submitter
50.
GRCh37:
Chr12:111351029
GRCh38:
Chr12:110913225
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Oct 13, 2021)
criteria provided, single submitter
51.
GRCh37:
Chr12:111357016
GRCh38:
Chr12:110919212
LOC114827850, MYL2Hypertrophic cardiomyopathy 10Likely benign
(Nov 17, 2021)
criteria provided, single submitter
52.
GRCh37:
Chr12:111353609
GRCh38:
Chr12:110915805
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Jul 27, 2021)
criteria provided, single submitter
53.
GRCh37:
Chr12:111356899
GRCh38:
Chr12:110919095
LOC114827850, MYL2Hypertrophic cardiomyopathy 10Likely benign
(Oct 17, 2021)
criteria provided, single submitter
54.
GRCh37:
Chr12:111353610
GRCh38:
Chr12:110915806
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Jun 20, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr12:111356893
GRCh38:
Chr12:110919089
LOC114827850, MYL2Hypertrophic cardiomyopathy 10Likely benign
(Jul 21, 2021)
criteria provided, single submitter
56.
GRCh37:
Chr12:111350968
GRCh38:
Chr12:110913164
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Mar 14, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr12:111357002-111357003
GRCh38:
Chr12:110919198-110919199
LOC114827850, MYL2Hypertrophic cardiomyopathy 10Likely benign
(Dec 2, 2021)
criteria provided, single submitter
58.
GRCh37:
Chr12:111352081
GRCh38:
Chr12:110914277
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Mar 13, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr12:111353501
GRCh38:
Chr12:110915697
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Jun 25, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr12:111350965
GRCh38:
Chr12:110913161
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Mar 22, 2021)
criteria provided, single submitter
61.
GRCh37:
Chr12:111348881
GRCh38:
Chr12:110911077
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Feb 25, 2021)
criteria provided, single submitter
62.
GRCh37:
Chr12:111356971
GRCh38:
Chr12:110919167
LOC114827850, MYL2Hypertrophic cardiomyopathy 10Likely benign
(Aug 15, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr12:111356904
GRCh38:
Chr12:110919100
LOC114827850, MYL2Hypertrophic cardiomyopathy 10Uncertain significance
(Mar 24, 2021)
criteria provided, single submitter
64.
GRCh37:
Chr12:111352061-111352067
GRCh38:
Chr12:110914257-110914263
MYL2I66fsHypertrophic cardiomyopathy 10Uncertain significance
(Mar 17, 2021)
criteria provided, single submitter
65.
GRCh37:
Chr12:111356966
GRCh38:
Chr12:110919162
MYL2, LOC114827850G12DHypertrophic cardiomyopathy 10Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
66.
GRCh37:
Chr12:111352052
GRCh38:
Chr12:110914248
MYL2K71MHypertrophic cardiomyopathy 10Uncertain significance
(Aug 7, 2021)
criteria provided, single submitter
67.
GRCh37:
Chr12:111351050-111351051
GRCh38:
Chr12:110913246-110913247
MYL2Y118fsHypertrophic cardiomyopathy 10Uncertain significance
(Jul 12, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr12:111348886
GRCh38:
Chr12:110911082
MYL2D166HHypertrophic cardiomyopathy 10Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
69.
GRCh37:
Chr12:111353553
GRCh38:
Chr12:110915749
MYL2D45EHypertrophic cardiomyopathy 10Uncertain significance
(Aug 30, 2021)
criteria provided, single submitter
70.
GRCh37:
Chr12:111348999
GRCh38:
Chr12:110911195
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Sep 15, 2021)
criteria provided, single submitter
71.
GRCh37:
Chr12:111356955
GRCh38:
Chr12:110919151
LOC114827850, MYL2N16DHypertrophic cardiomyopathy 10Uncertain significance
(Jun 13, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr12:111353528
GRCh38:
Chr12:110915724
MYL2A54SHypertrophic cardiomyopathy 10Uncertain significance
(Aug 26, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr12:111356973
GRCh38:
Chr12:110919169
LOC114827850, MYL2A10PHypertrophic cardiomyopathy 10Uncertain significance
(Sep 8, 2021)
criteria provided, single submitter
74.
GRCh37:
Chr12:111351034
GRCh38:
Chr12:110913230
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Apr 12, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr12:111356930
GRCh38:
Chr12:110919126
LOC114827850, MYL2T24IHypertrophic cardiomyopathy 10Uncertain significance
(Aug 31, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr12:111356907
GRCh38:
Chr12:110919103
LOC114827850, MYL2Hypertrophic cardiomyopathy 10Uncertain significance
(Jul 12, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr12:111350908
GRCh38:
Chr12:110913104
MYL2K132QHypertrophic cardiomyopathy 10Uncertain significance
(Aug 24, 2021)
criteria provided, single submitter
78.
GRCh37:
Chr12:111351990
GRCh38:
Chr12:110914186
MYL2G92RHypertrophic cardiomyopathy 10Uncertain significance
(Aug 24, 2021)
criteria provided, single submitter
79.
GRCh37:
Chr12:111353613
GRCh38:
Chr12:110915809
MYL2Hypertrophic cardiomyopathy 10Likely benign
(Feb 16, 2021)
criteria provided, single submitter
80.
GRCh37:
Chr12:111351084-111351087
GRCh38:
Chr12:110913280-110913283
MYL2F106fsHypertrophic cardiomyopathy 10Uncertain significance
(Nov 18, 2020)
criteria provided, single submitter
81.
GRCh37:
Chr12:111350946
GRCh38:
Chr12:110913142
MYL2V119DHypertrophic cardiomyopathy 10Uncertain significance
(Aug 10, 2021)
criteria provided, single submitter
82.
GRCh37:
Chr12:111352046
GRCh38:
Chr12:110914242
MYL2A73DHypertrophic cardiomyopathy 10Uncertain significance
(Sep 1, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr12:111352092
GRCh38:
Chr12:110914288
MYL2R58*Hypertrophic cardiomyopathy 10Uncertain significance
(Aug 29, 2021)
criteria provided, single submitter
84.
GRCh37:
Chr12:111356909
GRCh38:
Chr12:110919105
LOC114827850, MYL2E31GHypertrophic cardiomyopathy 10Uncertain significance
(Oct 23, 2021)
criteria provided, single submitter
85.
GRCh37:
Chr12:111351120
GRCh38:
Chr12:110913316
MYL2P95SHypertrophic cardiomyopathy 10Uncertain significance
(Sep 23, 2021)
criteria provided, single submitter
86.
GRCh37:
Chr12:111348957
GRCh38:
Chr12:110911153
MYL2F142SHypertrophic cardiomyopathy 10Uncertain significance
(Feb 5, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr12:111351108
GRCh38:
Chr12:110913304
MYL2I99VHypertrophic cardiomyopathy 10Uncertain significance
(Aug 31, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr12:111350902
GRCh38:
Chr12:110913098
MYL2E134*Hypertrophic cardiomyopathy 10Uncertain significance
(Feb 23, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr12:111348896
GRCh38:
Chr12:110911092
MYL2Cardiovascular phenotype, Hypertrophic cardiomyopathy 10Likely benign
(Sep 20, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr12:111356951
GRCh38:
Chr12:110919147
MYL2, LOC114827850V17AHypertrophic cardiomyopathy 10, Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy, Hypertrophic cardiomyopathy 10
Uncertain significance
(Oct 15, 2021)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr12:111351113
GRCh38:
Chr12:110913309
MYL2E97VHypertrophic cardiomyopathy 10Uncertain significance
(Jun 13, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr12:111351078
GRCh38:
Chr12:110913274
MYL2E109*Hypertrophic cardiomyopathy 10Uncertain significance
(Jul 6, 2021)
criteria provided, single submitter
93.
GRCh37:
Chr12:111351986
GRCh38:
Chr12:110914182
MYL2Hypertrophic cardiomyopathy 10Uncertain significance
(Nov 1, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr12:111353555
GRCh38:
Chr12:110915751
MYL2D45NHypertrophic cardiomyopathy 10Uncertain significance
(Feb 10, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr12:111356954
GRCh38:
Chr12:110919150
LOC114827850, MYL2N16fsCardiovascular phenotypeUncertain significance
(Nov 1, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr12:111358318
GRCh38:
Chr12:110920514
LOC114827850, MYL2Hypertrophic cardiomyopathy 10Uncertain significance
(Oct 14, 2021)
criteria provided, single submitter
97.
GRCh37:
Chr12:111356975
GRCh38:
Chr12:110919171
LOC114827850, MYL2R9KHypertrophic cardiomyopathy 10Uncertain significance
(Sep 24, 2021)
criteria provided, single submitter
98.
GRCh37:
Chr12:111352047
GRCh38:
Chr12:110914243
MYL2A73SHypertrophic cardiomyopathy 10Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
99.
GRCh37:
Chr12:111348898
GRCh38:
Chr12:110911094
MYL2G162*Hypertrophic cardiomyopathy 10Uncertain significance
(Oct 25, 2021)
criteria provided, single submitter
100.
GRCh37:
Chr12:111356897
GRCh38:
Chr12:110919093
LOC114827850, MYL2Hypertrophic cardiomyopathy 10Uncertain significance
(Aug 9, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination